ArticleHeliyon2024

Case report: Successful treatment of advanced urothelial carcinoma with trophoblastic differentiation using Tislelizumab and Disitamab vedotin.

Yaqian Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.